Division Of Gastroenterology And Hepatology 1
1. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
2. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
3. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
4. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
5. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
6. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
7. Global Hospitalization Trends for Crohns Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
8. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
9. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
10. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
11. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition
12. Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
13. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
14. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
15. Global evolution of inflammatory bowel disease across epidemiologic stages
16. Global evolution of inflammatory bowel disease across epidemiologic stages
17. Global evolution of inflammatory bowel disease across epidemiologic stages
18. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
19. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
20. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
21. A global action agenda for turning the tide on fatty liver disease
22. A global action agenda for turning the tide on fatty liver disease
23. A global action agenda for turning the tide on fatty liver disease
24. A global action agenda for turning the tide on fatty liver disease
25. A global action agenda for turning the tide on fatty liver disease
26. A global action agenda for turning the tide on fatty liver disease
27. A global action agenda for turning the tide on fatty liver disease
28. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
29. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)
30. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
31. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
32. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
33. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study
34. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
35. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
36. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
37. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
38. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
39. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
40. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
41. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
42. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
43. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
44. The case for simplifying and using absolute targets for viral hepatitis elimination goals
45. The case for simplifying and using absolute targets for viral hepatitis elimination goals
46. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
47. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
48. Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
49. Global burden of metabolic diseases, 1990–2021
50. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
1 2